Using Drosophila models of neurodegenerative diseases for drug discovery

Author： Newman Tracey   Sinadinos Christopher   Johnston Alex   Sealey Megan   Mudher Amrit  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.2, 2011-02, pp. : 129-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila

By Konsolaki Mary  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 12, 2013-12 ,pp. : 1503-1513

Informa Healthcare

Access to resources Recommend Favorite

Using Caenorhabditis elegans for antimicrobial drug discovery

By Desalermos Athanasios   Muhammed Maged   Glavis-Bloom Justin   Mylonakis Eleftherios  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

Ovarian follicles without oocytes in Drosophila

By  

Reproductive BioMedicine Online, Vol. 8, Iss. 5, 2004-05 ,pp. : 546-546

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Co-ordination of growth in Drosophila gonads

By  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 753-753

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Experimental models for anxiolytic drug discovery in the era of omes and omics

By Stewart Adam   Gaikwad Siddharth   Hart Peter   Kyzar Evan   Roth Andrew   Kalueff Allan V  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 7, 2011-07 ,pp. : 755-769

Informa Healthcare

Access to resources Recommend Favorite